Who is sponsoring NCT05196126?

NCT05196126 is sponsored by Stec, Sebastian, MD, PhD, FESC.

What drugs are being tested in NCT05196126?

Interventions in NCT05196126: Permament pacemaker implantation, Cardioneuroablation.

What condition does NCT05196126 study?

NCT05196126 studies Sinus Node Dysfunction.

Is NCT05196126 still recruiting?

NCT05196126 is currently status unknown. Last updated 7 March 2023.

Last reviewed 2023-03-07 · How we verify

NCT05196126: SANOK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Permanent Pacemaker Implantation or Cardioneuroablation in Sinus Node Dysfunction

Status unknown NA Last updated 7 March 2023

What this trial tests

NA trial testing Permament pacemaker implantation in Sinus Node Dysfunction in 60 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
31 May 2024

30 June 2024

Quick facts

Lead sponsor	Stec, Sebastian, MD, PhD, FESC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	1 June 2022
Primary completion	31 May 2024
Estimated completion	30 June 2024
Sites	4 locations across Poland

Drugs / interventions tested

Permament pacemaker implantation
Cardioneuroablation

Conditions studied

Sinus Node Dysfunction — all drugs for Sinus Node Dysfunction →

Sponsor

Stec, Sebastian, MD, PhD, FESC

Who can join

Adults 18 to 75, any sex, with Sinus Node Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a noncommercial, physician-initiated, monitored, multicenter, prospective randomized clinical trial, a proof-of-concept study, investigating a treatment strategy only. The study will use medical products applied for invasive and nonivasive procedures performed at the participating centers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Rationale and design of SAN.OK randomized clinical trial and registry: Comparison of the effects of evidence-based pacemaker therapy and cardioneuroablation in sinus node dysfunction.
Stec S, Jankowska-Polańska B, Jagielski D, Wileczek A, et al · · 2022 · cited 5× · PMID 36385604 · DOI 10.5603/cj.a2022.0103

Verify or expand the search:

Other recruiting trials for Sinus Node Dysfunction

Currently open trials in the same condition.

NCT07209852 — Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05196126 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stec, Sebastian, MD, PhD, FESC
Last refreshed: 7 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05196126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing